OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
002030 Daan Gene Co.,Ltd.
- 6.09
- +0.22+3.75%
Trading Apr 1 13:49 CST
8.55BMarket Cap-9.24P/E (TTM)
6.18High5.88Low214.41KlotVolume5.88Open5.87Pre Close130.55MTurnover1.53%Turnover RatioLossP/E (Static)1.40BShares7.8452wk High1.08P/B8.55BFloat Cap4.7152wk Low6.46Limit Up1.40BShs Float29.99Historical High5.28Limit Down5.11%Amplitude-2.92Historical Low0.02Dividend TTM6.09Avg Price84.38KlotAsk0.25%Div YieldTTM100Lot Size128.77KlotBid
Daan Gene Co.,Ltd. Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -12.74%872.09M | -23.01%773.44M | -12.75%756.26M | -61.72%798.47M | -61.48%999.37M | -50.11%1B | -54.46%866.79M | -17.02%2.09B | 19.07%2.59B | -26.73%2.01B |
| Transactional financial assets | -30.06%63M | 40.06%161.07M | 194.12%150.01M | -93.24%27.8M | -81.27%90.08M | -41.62%115M | -44.57%51M | 53.36%411.05M | 26.55%480.9M | -42.06%197M |
| Notes receivable and accounts receivable | -39.13%1.26B | -41.18%1.46B | -42.40%1.69B | -46.40%1.88B | -49.50%2.06B | -41.22%2.49B | -29.66%2.93B | 3.20%3.5B | 79.19%4.08B | 84.06%4.23B |
| -Notes receivable | -78.53%1M | -59.22%572.13K | -58.34%797.53K | 8.78%4M | -74.55%4.67M | -95.48%1.4M | -88.76%1.91M | -79.90%3.68M | -5.82%18.37M | 69.58%31.06M |
| -Accounts receivable | -39.05%1.25B | -41.17%1.46B | -42.39%1.69B | -46.45%1.87B | -49.39%2.06B | -40.82%2.49B | -29.41%2.93B | 3.65%3.5B | 79.93%4.07B | 84.18%4.2B |
| Other receivables (including interest and dividends) | -32.76%33.62M | -4.38%51.76M | -57.20%43.24M | -27.83%46.83M | -5.22%50M | -37.12%54.13M | -11.60%101.03M | -8.78%64.88M | -6.56%52.76M | 277.22%86.08M |
| -Dividend receivable | --0 | --0 | -92.21%3.82M | --0 | --6.15M | --0 | --49.08M | --0 | --0 | --0 |
| -Accrued interest receivable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Other receivable | -23.33%33.62M | -4.38%51.76M | -24.12%39.42M | -27.83%46.83M | -16.88%43.85M | -37.12%54.13M | -54.55%51.95M | -8.78%64.88M | -6.56%52.76M | 277.22%86.08M |
| Contractual assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Advance payment | 15.90%49.83M | -46.31%56.21M | -62.79%45.83M | -61.81%48.99M | -56.62%42.99M | -51.40%104.69M | -55.60%123.16M | -46.29%128.28M | -45.73%99.09M | 27.49%215.42M |
| Inventories | -17.25%198.21M | -38.10%238.32M | -39.14%258.06M | -39.96%251.3M | -35.19%239.52M | -38.31%385.04M | -43.46%424.01M | -31.22%418.52M | -25.14%369.6M | 50.96%624.13M |
| Receivable financing | -84.85%6.28M | 269.99%36.48M | 1,058.14%77.46M | 353.43%82.84M | -14.82%41.46M | --9.86M | --6.69M | --18.27M | --48.67M | --0 |
| Assets held for sale | -2.82%206.3M | -0.22%212.27M | -0.23%212.27M | -0.23%212.27M | -0.22%212.29M | -0.01%212.73M | -0.00%212.75M | -0.00%212.75M | -0.00%212.76M | -4.42%212.76M |
| Non-current assets due within one year | -31.60%72.75M | 31.72%95.09M | 51.88%121.09M | -11.59%106.36M | -12.57%106.35M | -88.27%72.19M | -70.85%79.72M | -33.86%120.3M | 48.56%121.64M | 498.98%615.39M |
| Other current assets | -30.12%1.02B | 228.70%1.95B | 633.39%1.89B | 184.25%2.05B | 107.88%1.47B | 412.11%593.74M | 49.89%258.14M | 530.54%719.46M | 490.35%704.98M | 94.06%115.94M |
| Total current assets | -28.79%3.78B | 0.01%5.04B | 3.78%5.25B | -28.44%5.5B | -39.44%5.31B | -39.37%5.04B | -36.52%5.05B | 1.04%7.68B | 46.52%8.77B | 30.33%8.31B |
| Non Current assets | ||||||||||
| Debt investment | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Other debt investment | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Other equity investment | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Other non-current financial assets | -15.74%910.56M | -8.38%961.21M | -31.29%773.58M | 6.68%715.04M | 67.33%1.08B | 98.52%1.05B | 105.80%1.13B | 17.51%670.24M | 12.95%645.78M | -5.29%528.49M |
| Investment real estate | -4.89%26.26M | 25.12%26.44M | 27.92%27.19M | 25.89%26.91M | 27.00%27.61M | 9.60%21.13M | 9.05%21.25M | 1.04%21.38M | -1.67%21.74M | -6.80%19.28M |
| Long-term equity investment | -39.01%516.34M | -25.42%664.12M | -14.49%778.51M | -17.95%815.8M | -16.04%846.54M | -13.15%890.46M | -9.04%910.44M | 8.59%994.24M | 18.40%1.01B | 29.20%1.03B |
| Long term receivable account | 143.56%87.47M | 62.08%58.35M | -59.35%36.96M | -53.54%29.16M | -50.16%35.91M | -17.56%36M | 151.44%90.93M | 247.30%62.76M | 333.57%72.05M | -22.92%43.67M |
| Fixed assets | -14.24%995.99M | ---- | -11.37%1.06B | ---- | 2.37%1.16B | ---- | 24.50%1.19B | ---- | 100.04%1.13B | ---- |
| Fixed assets liquidation | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | --0 | ---- |
| Constru in process | 6.70%776.1M | ---- | 3.72%790.32M | ---- | 26.14%727.35M | ---- | 387.33%761.97M | ---- | 173.74%576.63M | ---- |
| Construction materials | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | --0 | ---- |
| Productive biological assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Oil and gas assets | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Intangible assets | 104.77%572.72M | 35.48%376.95M | 31.73%349.9M | 56.24%337.49M | 37.03%279.7M | 62.74%278.24M | 84.21%265.61M | 47.37%216.01M | 77.45%204.12M | 48.10%170.97M |
| Development expenditure | -43.43%346.89M | -8.98%543.39M | -4.27%557.56M | -2.09%568.74M | 14.65%613.19M | 38.42%597.03M | 55.36%582.43M | 88.92%580.91M | 89.75%534.84M | 91.43%431.32M |
| Goodwill | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Long deferred expense | -11.52%50.68M | -10.01%50.47M | -7.40%52.72M | 17.69%55.08M | 42.91%57.29M | -3.67%56.08M | 25.06%56.93M | -2.24%46.8M | -19.29%40.08M | 12.72%58.22M |
| Deferred tax assets | 56.58%358.39M | 58.35%288.85M | 52.29%281.75M | 31.58%265.19M | 14.83%228.9M | 35.21%182.41M | 41.50%185.01M | 82.37%201.54M | 76.89%199.34M | 95.61%134.91M |
| Usufruct assets | 23.37%17.48M | -16.98%11.84M | -11.99%15.21M | -39.29%13.08M | -74.76%14.17M | -81.15%14.26M | -81.71%17.28M | -76.62%21.55M | -34.17%56.14M | -15.30%75.67M |
| Other non current assets | 80.60%1.12B | -88.55%139.31M | -89.98%144.61M | -90.95%136.38M | -58.58%619.01M | -27.48%1.22B | -12.83%1.44B | -17.86%1.51B | 1.90%1.49B | 1,764.36%1.68B |
| Total non current assets | 1.53%5.8B | -21.15%4.95B | -26.66%4.88B | -20.74%4.88B | -4.68%5.71B | 13.25%6.27B | 28.84%6.65B | 24.15%6.15B | 37.61%5.99B | 101.69%5.54B |
| Total assets | -13.08%9.58B | -11.72%9.98B | -13.52%10.13B | -25.01%10.37B | -25.34%11.02B | -18.33%11.31B | -10.81%11.71B | 10.16%13.84B | 42.77%14.76B | 51.81%13.85B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | -56.61%143.53M | -50.36%146.26M | -64.41%111.7M | 285.51%326.57M | 193.40%330.8M | 302.94%294.66M | 28.20%313.8M | -64.16%84.71M | -56.60%112.75M | -70.78%73.13M |
| Transactional financial liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Notes payable and accounts payable | -15.88%357.87M | 0.31%384.69M | -28.88%405.6M | -35.83%391.78M | -42.28%425.44M | -50.35%383.51M | -44.56%570.34M | -25.53%610.58M | 33.28%737.07M | -3.93%772.36M |
| -Notes payable | --0 | --0 | --0 | --0 | --0 | --0 | --98.92M | --0 | --0 | --0 |
| -Accounts payable | -15.88%357.87M | 0.31%384.69M | -13.96%405.6M | -35.83%391.78M | -42.28%425.44M | -50.35%383.51M | -54.17%471.42M | -25.53%610.58M | 33.28%737.07M | -3.93%772.36M |
| Contract liabilities | 93.45%66.23M | -64.36%36.51M | -67.96%35.19M | -36.61%40.44M | -50.63%34.23M | 27.92%102.45M | 11.78%109.83M | -50.95%63.79M | -54.52%69.34M | -27.08%80.09M |
| Advance receipts | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --16.89M | --0 | --0 |
| Salaries payable | -25.97%525.67M | -34.02%489.97M | -35.34%510.7M | -36.74%533.7M | -50.33%710.1M | -20.72%742.58M | -16.48%789.77M | -13.95%843.61M | 52.93%1.43B | 40.72%936.65M |
| Taxs payable | -33.22%35.51M | -38.73%30.97M | -33.43%33.7M | -81.88%36.29M | -84.38%53.17M | -90.24%50.55M | -91.70%50.62M | -70.04%200.27M | -16.36%340.42M | 39.05%518.17M |
| Other payable (including interest and dividends) | -0.24%107.03M | 4.00%87.66M | -19.60%107.44M | -42.35%89.15M | -41.55%107.29M | -4.35%84.29M | 43.90%133.63M | 53.41%154.65M | 87.02%183.56M | -15.55%88.12M |
| -Interest payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Dividend payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Other payable | -0.24%107.03M | 4.00%87.66M | -19.60%107.44M | -42.35%89.15M | -41.55%107.29M | -4.35%84.29M | 43.90%133.63M | 53.41%154.65M | 87.02%183.56M | -15.55%88.12M |
| Hold and for sell liabilities | 0.00%42.72M | 0.00%42.55M | 0.00%42.55M | 0.00%42.55M | 0.00%42.72M | 0.00%42.55M | 0.00%42.55M | -0.39%42.55M | 0.00%42.72M | -0.39%42.55M |
| Non current liabilities due within one year | -30.97%10.7M | 9.87%10.11M | -32.18%14.8M | -69.53%7.87M | -65.68%15.51M | -78.14%9.2M | -51.82%21.83M | -41.58%25.84M | -0.31%45.18M | 528.63%42.07M |
| Other current liabilities | 145.57%4.49M | -54.64%1.34M | -89.74%1.39M | -13.93%1.87M | -77.48%1.83M | -82.40%2.94M | -58.85%13.59M | -92.97%2.18M | -70.81%8.11M | -43.96%16.73M |
| Total current liabilities | -24.83%1.29B | -28.18%1.23B | -38.27%1.26B | -28.11%1.47B | -42.03%1.72B | -33.35%1.71B | -34.87%2.05B | -33.03%2.05B | 17.76%2.97B | 7.71%2.57B |
| Current liabilities | ||||||||||
| Long term loan | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Bonds payable | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Perpetual Debt | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Long term account payable | 3.89%5.5M | ---- | -31.18%4.63M | ---- | -11.25%5.3M | ---- | 29.04%6.72M | ---- | -52.82%5.97M | ---- |
| Long term salaries pay | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Specific account payable | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | --0 | ---- |
| Estimate liabilities | 1,153.09%1.43M | --97.97K | -96.81%113.92K | -99.43%113.92K | -99.52%113.92K | --0 | --3.57M | --20.06M | --23.84M | --0 |
| Deferred tax liabilities | -23.31%61.24M | -16.68%66.7M | -46.54%48.87M | -8.64%49.41M | 66.47%79.85M | 107.79%80.05M | 115.64%91.43M | 18.16%54.08M | 2.12%47.97M | -8.55%38.52M |
| Long term deferred income | 79.05%58.53M | 94.32%64.33M | 96.43%71.22M | -11.28%29.3M | 19.86%32.69M | 35.62%33.1M | 38.69%36.26M | 24.49%33.03M | -9.51%27.27M | -18.19%24.41M |
| Lease liabilities | -38.32%13.46M | -52.54%15.35M | -30.86%18.6M | 0.62%23.8M | -67.62%21.81M | -43.69%32.34M | -64.74%26.89M | -67.84%23.66M | 2.59%67.38M | -37.24%57.43M |
| Other non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Total non current liabilities | 0.28%140.15M | 0.45%152.09M | -13.00%143.43M | -20.93%108.08M | -18.94%139.76M | 22.99%151.41M | 9.89%164.87M | -11.76%136.68M | 10.93%172.42M | -34.51%123.11M |
| Total liabilities | -22.94%1.43B | -25.86%1.38B | -36.38%1.41B | -27.66%1.58B | -40.76%1.86B | -30.78%1.86B | -32.83%2.21B | -32.01%2.18B | 17.36%3.14B | 4.63%2.69B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%1.4B | 0.00%1.4B | 0.00%1.4B | 0.00%1.4B | 0.00%1.4B | 0.00%1.4B | 0.00%1.4B | 0.00%1.4B | 0.00%1.4B | 0.00%1.4B |
| Other equity instruments | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Equity of prefer stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Equity of Perpetual debt | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Capital reserve funds | -7.76%600.97M | -6.18%618.68M | -4.09%632.49M | -9.51%651.54M | -9.51%651.54M | -13.07%659.45M | -13.07%659.45M | 15.87%719.99M | 15.87%719.99M | 12.82%758.62M |
| Surplus reserve funds | 0.00%1.27B | 1.71%1.27B | 1.71%1.27B | 1.71%1.27B | 1.71%1.27B | 77.78%1.25B | 77.78%1.25B | 77.78%1.25B | 77.78%1.25B | 96.90%703.22M |
| Retained profit | -17.03%4.61B | -13.61%5.03B | -12.59%5.14B | -34.80%5.19B | -29.92%5.56B | -26.94%5.83B | -11.75%5.88B | 26.40%7.97B | 71.55%7.93B | 105.82%7.98B |
| Less:Treasury stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Other composite income | -89.07%-7.41M | -44.27%-3.76M | -30.62%-3.48M | -18.81%-3.7M | -37.41%-3.92M | -190.86%-2.6M | -294.87%-2.66M | -622.13%-3.11M | -675.84%-2.85M | 291.35%2.87M |
| Ordinary risk reserve funds | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Specific reserves | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Shareholders equity without minority interests | -11.26%7.88B | -8.90%8.32B | -8.12%8.44B | -24.88%8.52B | -21.42%8.88B | -15.74%9.14B | -3.56%9.19B | 25.53%11.34B | 53.73%11.3B | 71.88%10.84B |
| Minority interests | -4.97%263.07M | -9.87%278.01M | -10.36%278.45M | -11.69%278.98M | -12.06%276.83M | -1.00%308.47M | 0.09%310.64M | -0.94%315.9M | 1.99%314.79M | 30.08%311.6M |
| Total shareholder equity | -11.07%8.14B | -8.94%8.6B | -8.19%8.72B | -24.52%8.8B | -21.17%9.16B | -15.33%9.45B | -3.44%9.5B | 24.63%11.65B | 51.64%11.62B | 70.35%11.16B |
| Total liabilityies and equity | -13.08%9.58B | -11.72%9.98B | -13.52%10.13B | -25.01%10.37B | -25.34%11.02B | -18.33%11.31B | -10.81%11.71B | 10.16%13.84B | 42.77%14.76B | 51.81%13.85B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.